CONOTOXINS

A substantially pure conotoxin which is highly selective for a specific human receptor, which conotoxin is selected from the group consisting of: Glu-Ser-Glu-Glu-Gly-Gly-Ser-Asn-Ala-Thr-Lys-Lys-Pro- Tyr-Ile-Leu (SEQ ID NO:13) wherein Glu in the 1-position is pGlu and the C-terminus is amidated; Gly-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ABOGADIE, FE, OLIVERA, BALDOMERO M, HOPKINS, CHRIS E, RIVIER, JEAN E.F, DYKERT, JOHN, TORRES, JOSEP L, CRUZ, LOURDES J
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A substantially pure conotoxin which is highly selective for a specific human receptor, which conotoxin is selected from the group consisting of: Glu-Ser-Glu-Glu-Gly-Gly-Ser-Asn-Ala-Thr-Lys-Lys-Pro- Tyr-Ile-Leu (SEQ ID NO:13) wherein Glu in the 1-position is pGlu and the C-terminus is amidated; Gly-Glu-Xaa-Xaa-Va1-Ala-Lys-Met-Ala-Ala-Xaa-Leu-Ala- Arg-Xaa-Asn-Ile-Ala-Lys-Gly-Cys-Lys-Val-Asn-Cys-Tyr- Pro (SEQ ID NO:12) wherein Xaa is Gla; Ser-Thr-Ser-Cys-Met-Glu-Ala-Gly-Ser-Tyr-Cys-Gly-Ser- Thr-Thr-Arg-Ile-Cys-Cys-Gly-Tyr-Cys-Ala-Tyr-Phe-Gly- Lys-Lys-Cys-Ile-Asp-Tyr-Pro-Ser-Asn (SEQ ID NO:11); Cys-Lys-Thr-Tyr-Ser-Lys-Tyr-Cys-Xaa-Ala-Asp-Ser-Xaa- Cys-Cys-Thr-Xaa-Gln-Cys-Val-Arg-Ser-Tyr-Cys-Thr-Leu- Phe (SEQ ID NO:10) wherein Xaa is Gla and the C-terminus is amidated; His-Xaa-Xaa-Cys-Cys-Leu-Tyr-Gly-Lys-Cys-Arg-Arg-Tyr- Xaa-Gly-Cys-Ser- Ser-Ala-Ser-Cys-Cys-Gln (SEQ ID NO:9) wherein Xaa is 4Hyp; Gly-Cys-Cys-Ser-His-Pro-Ala-Cys-Ser-Gly-Lys-Tyr-Gln- Xaa-Tyr-Cys-Arg- Xaa- Ser (SEQ ID NO:8) wherein Xaa is Gla and the C-terminus is amidated; and Gly-Xaa-Ser-Phe-Cys-Lys-Ala-Asp-Glu-Lys-Xaa-Cys-Glu- Tyr-His-Ala-Asp-Cys-Cys-Asn-Cys-Cys-Leu-Ser-Gly-Ile- Cys-Ala-Xaa-Ser-Thr-Asn-Trp-Ile-Leu-Pro-Gly-Cys-Ser- Thr-Ser-Ser-Phe-Phe-Lys-Ile (SEQ ID NO:7) wherein Xaa is 4Hyp. These conotoxins may be used to prepare medicaments for the treatment of neuromuscular disorders. Some may be used for rapid reversible immobilisation of muscles or for diagnosing myasthenia gravis or Lambert-Eaton myasthenic syndrome.